23 Jan 2019 13:10
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. | Details of PDMR/person closely associated with them ('PCA') | |||||
a) | Name | Mr B McNamara | ||||
b) | Position/status | CEO, GSK Consumer Healthcare | ||||
c) | Initial notification/ amendment | Initial notification | ||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | GlaxoSmithKline plc | ||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||
a) | Description of the financial  instrument | American Depositary Shares ('ADSs')  ISIN: US37733W1053  | ||||
b) | Nature of the transaction | The vesting of an award over 8,994 ADSs made under the GlaxoSmithKline Share Value Plan. Of the vested award, 4,430 ADSs were automatically withheld to meet tax liabilities. | ||||
c) | Price(s) and volume(s) |
 | ||||
d) | Aggregated information  Aggregated volume Price | n/a (single transaction)       | ||||
e) | Date of the transaction | 2019-01-22 | ||||
f) | Place of the transaction  | New York Stock Exchange (XNYS) |
Â
Â